Empty Capsules Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Empty Capsules Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • March 2022 •
  • 147 pages •
  • Report ID: 6247080 •
  • Format: PDF
The global empty capsules market reached a value of US$ 2.61 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 4.14 Billion by 2027 exhibiting a CAGR of 7.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Empty capsules refer to a stable shell encapsulating medicines that are administered in the patient’s body in various dosage forms, such as granules and pellets. They are commercially available in two varying types, gelatin and non-gelatin. The gelatin capsules (hard and soft) are a high collagen animal-based medicine manufactured from pig meat and beef and chicken connective tissues. On the other hand, the non-gelatin, or vegetarian capsule, is produced from the blend of starch and hydroxypropyl methylcellulose (HPMC). Currently, empty capsules find extensive applications in healthcare and therapeutic applications.

Empty Capsules Market Trends:
The increasing prevalence of cardiovascular and chronic diseases and the rising geriatric population are some of the key factors driving the empty capsule market growth. In line with this, the introduction of capsule-in-capsule technology to ensure gastrointestinal safety of those patients that did not receive capsule medication is another growth-inducing factor. Moreover, the rising demand for the immediate-release capsule by manufacturers for producing various medicinal products, such as antibacterial, antiacids, inhalers, dietary supplements, painkillers, and antibiotics, are contributing to the market growth. The rapid expansion in the healthcare industry and the widespread adoption of non-gelatin capsules, such as hydroxypropyl methylcellulose (HPMC) due to its moderate strength, transparency, and resistance to oil and fat properties, are propelling the market growth. Additionally, the increasing investments in the research and development (R&D) activities in the healthcare sector for introducing innovative therapeutics and pharmaceutical drugs is positively stimulating the market growth. Other factors, such as the easy access to advanced treatment options, strategic collaborations between the empty capsule suppliers and gelatin manufacturers, and the growing demand for various dietary supplements, immunity boosters, and drugs, are creating a positive outlook for the market.

Key Market Segmentation:
the analyst provides an analysis of the key trends in each sub-segment of the global empty capsules market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, raw material, functionality, therapeutic application and end user.

Breakup by Type:
Gelatin Capsule
Non-gelatin Capsule

Breakup by Raw Material:
Pig Meat
Bovine Meat
Hydroxypropyl Methylcellulose (HPMC)

Breakup by Functionality:
Immediate-release Capsules
Sustained-release Capsules
Delayed-release Capsules

Breakup by Therapeutic Application:
Antibiotic and Antibacterial Drugs
Vitamins and Dietary Supplements
Antacid and Antiflatulent Preparations
Cardiovascular Therapy Drugs

Breakup by End User:
Pharmaceutical Industry
Nutraceutical Industry
Cosmetics Industry

Breakup by Region:
North America
United States
South Korea
United Kingdom
Latin America
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being ACG Associated Capsules Pvt. Ltd., Bright Pharma Caps Inc., CapsCanada Corporation, HealthCaps India Limited, Lonza Group AG, Medicaps Limited, Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation), Nectar Lifesciences Limited, Roxlor LLC, Shanxi Guangsheng Medicinal Capsules Co. Ltd, Snail Pharma Industry Co. Ltd, Suheung Co. Ltd and Sunil Healthcare Limited.

Key Questions Answered in This Report:
How has the global empty capsules market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global empty capsules market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the raw material?
What is the breakup of the market based on the functionality?
What is the breakup of the market based on the therapeutic application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global empty capsules market and who are the key players?
What is the degree of competition in the industry?